• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

SVP Global Textiles Ltd
Industry :  Textiles - Spinning - Synthetic / Blended
BSE Code
ISIN Demat
Book Value()
505590
INE308E01029
-4.5699605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SVPGLOB
0
49.59
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

escorp asset management ltd
Astrazeneca Pharma India standalone net profit declines 22.95% in the March 2026 quarter
May 27,2026
Net profit of Astrazeneca Pharma India declined 22.95% to Rs 44.88 crore in the quarter ended March 2026 as against Rs 58.25 crore during the previous quarter ended March 2025. Sales rose 20.42% to Rs 578.61 crore in the quarter ended March 2026 as against Rs 480.48 crore during the previous quarter ended March 2025.

For the full year,net profit rose 62.02% to Rs 187.52 crore in the year ended March 2026 as against Rs 115.74 crore during the previous year ended March 2025. Sales rose 32.59% to Rs 2275.58 crore in the year ended March 2026 as against Rs 1716.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales578.61480.48 20 2275.581716.29 33
OPM %10.5317.98 -11.5114.80 -
PBDT64.82101.84 -36 286.03293.14 -2
PBT59.2284.15 -30 257.45253.15 2
NP44.8858.25 -23 187.52115.74 62